Measures of systemic sclerosis (scleroderma): Health Assessment Questionnaire (HAQ) and Scleroderma HAQ (SHAQ), physician- and patient-rated global assessments, Symptom Burden Index (SBI), University of California, Los Angeles, Scleroderma Clinical Trials Consortium Gastrointestinal Scale (UCLA SCTC GIT) 2.0, Baseline Dyspnea Index (BDI) and Transition Dyspnea Index (TDI) (Mahler's Index), Cambridge Pulmonary Hypertension Outcome Review (CAMPHOR), and Raynaud's Condition Score (RCS)

MeSH terms

• Clinical Trials as Topic / standards
• Cost of Illness
• Dyspnea / diagnosis*
• Dyspnea / epidemiology
• Gastrointestinal Diseases / diagnosis*
• Gastrointestinal Diseases / epidemiology
• Humans
• Hypertension, Pulmonary / diagnosis*
• Hypertension, Pulmonary / epidemiology
• Los Angeles
• Patient Satisfaction
• Physician's Role
• Raynaud Disease / diagnosis*
• Raynaud Disease / epidemiology
• Scleroderma, Systemic / diagnosis*
• Scleroderma, Systemic / epidemiology
• Severity of Illness Index
• Surveys and Questionnaires / standards*
• Universities / standards